Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Pilot Study Evaluating Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis.

NCT00587119 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00587119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00587119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Pilot Study Evaluating Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis.
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2007
Completion date
July 31, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hepatitis, primary biliary cirrhosis